# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Oppenheimer analyst Noah Kaye maintains Itron (NASDAQ:ITRI) with a Outperform and raises the price target from $110 to $112.
JP Morgan analyst Mark Strouse maintains Itron (NASDAQ:ITRI) with a Neutral and raises the price target from $104 to $112.
Roth MKM analyst Chip Moore maintains Itron (NASDAQ:ITRI) with a Buy and raises the price target from $112 to $122.
Guggenheim analyst Joseph Osha upgrades Itron (NASDAQ:ITRI) from Neutral to Buy and announces $130 price target.
Canaccord Genuity analyst Austin Moeller maintains Itron (NASDAQ:ITRI) with a Buy and raises the price target from $115 to $...
The offering size was increased from the previously announced offering size of $500 million aggregate principal amount of Notes...